Granahan Investment Management
BEAM icon

Granahan Investment Management’s Beam Therapeutics BEAM Stock Holding History

Granahan Investment Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-136,137
Closed -$4.17M – 176
2023
Q1 		$4.17M Sell
136,137
-27,653
-17% -$1.09M 0.13% 137
2022
Q4 		$6.41M Buy
163,790
+53,355
+48% +$2.39M 0.2% 115
2022
Q3 		$5.26M Buy
110,435
+29,507
+36% +$1.68M 0.17% 125
2022
Q2 		$3.13M Sell
80,928
-27,299
-25% -$1.09M 0.11% 143
2022
Q1 		$6.2M Buy
108,227
+24,835
+30% +$1.63M 0.15% 124
2021
Q4 		$6.65M Sell
83,392
-7,448
-8% -$638K 0.14% 136
2021
Q3 		$7.9M Sell
90,840
-11,683
-11% -$1.17M 0.15% 127
2021
Q2 		$13.2M Buy
102,523
+5,932
+6% +$473K 0.25% 95
2021
Q1 		$7.73M Sell
96,591
-17,467
-15% -$1.66M 0.16% 112
2020
Q4 		$9.31M Buy
114,058
+18,773
+20% +$923K 0.21% 95
2020
Q3 		$2.35M Sell
95,285
-1,313
-1% -$32.6K 0.08% 145
2020
Q2 		$2.71M Sell
96,598
-1,678
-2% -$36.2K 0.1% 139
2020
Q1 		$1.77M Buy
+98,276
New +$2.14M 0.1% 142

Other funds holding BEAM

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Granahan Investment Management's BEAM Position: Q2 2023 in Review

Granahan Investment Management sold out of Beam Therapeutics (BEAM) in Q2 2023, closing a stake of 136,137 shares — an estimated $4.17M sold.

Granahan Investment Management first reported a position in BEAM in Q1 2020 and held it in 13 quarters. The position peaked at $13.2M in Q2 2021. 193 funds tracked by Wall St. Rank hold BEAM as of Q2 2023.

  • Granahan Investment Management reported no remaining Beam Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Granahan Investment Management sold 136,137 Beam Therapeutics shares in Q2 2023, an estimated $4.17M.
  • Granahan Investment Management first reported a position in Beam Therapeutics in Q1 2020 and held it in 13 quarters.
  • Granahan Investment Management's Beam Therapeutics position peaked at $13.2M in Q2 2021.
  • 193 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2023.

Based on Granahan Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.